{"id":"W2745458550","doi":"10.21037/atm.2017.08.14","title":"EGFR mutation positive non-small cell lung cancer: can we identify predictors of benefit from immune checkpoint inhibitors","year":2017,"lang":"en","type":"letter","venue":"Annals of Translational Medicine","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University","funders":"","keywords":"Pembrolizumab; Atezolizumab; Nivolumab; Docetaxel; Medicine; Oncology; Epidermal growth factor receptor; Lung cancer; Internal medicine; Chemotherapy; Immunotherapy; Cancer; Cancer research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001010641,0.000398758,0.00131476,0.000754171,0.0006418414,0.001271626,0.0008011192,0.008415969,0.003149657],"category_scores_gemma":[0.01243604,0.0002640351,0.0004949339,0.0006514411,0.001142174,0.002115062,0.0003609973,0.00727304,0.003318068],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001686169,"about_ca_system_score_gemma":0.0009917973,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008481871,"about_ca_topic_score_gemma":0.001676698,"domain_scores_codex":[0.9993727,0.000232927,0.00008017282,0.00008282687,0.0001375935,0.00009380986],"domain_scores_gemma":[0.9962327,0.00254486,0.0002380019,0.0001100298,0.0004861674,0.0003881831],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002071005,0.0007556729,0.06442644,0.0003922674,0.0001259591,0.03217199,0.0002911829,0.0006097274,0.002666621,0.005653024,0.6343081,0.256528],"study_design_scores_gemma":[0.002761344,0.002348763,0.09919947,0.003384766,0.000616037,0.1383479,0.002261126,0.01250549,0.002947858,0.1094498,0.6258621,0.0003152627],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.02120596,0.01547214,0.0002784015,0.9460897,0.008661702,0.00003973922,0.0001179078,0.00006110581,0.008073343],"genre_scores_gemma":[0.1971358,0.02688462,0.001022667,0.5832741,0.1827483,0.000127289,0.0002572355,0.00005718746,0.008492757],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.008415969,"threshold_uncertainty_score":0.01223409,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02984021371563978,"score_gpt":0.3171127859218691,"score_spread":0.2872725722062294,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}